Abstract:Polyvalent ligand-induced cell receptor aggregation is closely related to cell behavior regulation. At present, most of the means to induce receptor aggregation rely on external stimuli such as light, heat, and magnetic fields, which may cause side effects to normal cells. How to achieve receptor aggregation on the cancer cell surface to achieve cell apoptosis selectively is still a challenge. Therefore, by taking advantage of the unique property of cancer cells' slightly acidic microenvironment, an easy-to-use apoptosis-inducing mode for the in situ activation of cell surface nucleolin clustering has been developed, which not only opened a new channel for nucleolin receptor aggregation to regulate cell function and further development but also avoided damage to normal cells, providing a new strategy for tumor treatment. Dual functional ssDNA (AS1411 aptamer and pH-responsive I-strand sequence) was modified on the surface of gold nanoparticles (AuNPs) to fabricate AI-Au intelligent nanomachines. Then, the specific binding on cancer cells and aggregation of the nucleolin receptors can be achieved via the formation of an i-Motif structure among adjacent AuNPs under the acidic microenvironment. The result showed that AI-Au nanomachines mediated nucleolin cross-linking on the cell surface, resulting in a cytotoxic effect of approximately 60%. Experiments such as calcein-AM/PI staining, nuclear dye staining, and flow cytometry demonstrated that cell apoptosis became more evident with the increase of acidity under the cell surface microenvironment. Immunofluorescence imaging further confirmed the Cyt-c/caspase-3 apoptosis pathway induced by AI-Au nanomachines. The proposed strategy used for specific cancer cell apoptosis by the in situ activation of tumor cell membrane receptor aggregation is inexpensive and simple to use, which not only provides a new means of nucleolin receptor aggregation for regulating cell function but also offers a new strategy for tumor treatment with reduced side effect to normal cells. This work is significant for comprehending the ligand-induced receptor aggregation process and can lead to the development of a promising anticancer drug.

High yield purification of an Isoleucine zipper modified CD95 Ligand with either biotin or DNA-oligomer binding domain for efficient Cell Apoptosis Induction

Slowly getting a clue on CD95 ligand biology.

[High Level Expression of Recombinant Human Scd40l-Iz and Identification of Its Biological Activation].

Engineering and refolding of a novel trimeric fusion protein TRAIL-collagen XVIII NC1

Efficient expression and primary purification of 6-his tagged human Fas ligand in Dictyostelium discoideum

[Preparation and Identification of Soluble Trimeric CD40-isoleucine Zipper Fusion Protein].

Production, purification and cytotoxity of soluble human Fas ligand expressed by Escherichia coli and Dictyostelium discoideum

An In-Tether Chiral Center Modulates the Proapoptotic Activity of the KLA Peptide.

Enhanced Production of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Escherichia Coli Using a Novel Self-Cleavable Tag System Fh8-ΔI-CM.

Potent Apoptosis Induction by a Novel Trispecific B7-H3xCD16xTIGIT 2+1 Common Light Chain Natural Killer Cell Engager

Optimization of culture conditions for stable expression of recombinant fc-fused human extracellular CD99 in HEK293T cells

Effect of Isoleucine Zipper Motif on the Biological Activity of Human Soluble CD40L

In Situ Activation of the Receptor Aggregation for Cell Apoptosis by an AI-Au Intelligent Nanomachine via Tumor Extracellular Acidity

A simplified method for the efficient purification and refolding of recombinant human TRAIL

Fusion Protein of CDR Mimetic Peptide with Fc Inhibit TNF-α Induced Cytotoxicity

Enhancement of Binding Activity of Soluble Human CD40 to CD40 Ligand Through Incorporation of an Isoleucine Zipper Motif

Expression , Purification and Biological Characterization of the Extracellular Domain of CD 40 from Pichia Pastoris

Cell Permeable Bcl-2 Binding Peptides: A Chemical Approach to Apoptosis Induction in Tumor Cells

[Expression of Modified Humanized Immunoapoptotic Protein and Its Specific Killing Effect on HER2-positive Tumor Cells].

Cell‐penetrating and Endoplasmic Reticulum‐locating TAT‐IL‐24‐KDEL Fusion Protein Induces Tumor Apoptosis

Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant B Cells